4.7 (631) In stock
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
Recombinant SARS-CoV-2 Spike His Protein, CF (10549-CV): Novus Biologicals
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies, The Egyptian Journal of Internal Medicine
Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions - ScienceDirect
Streamline your COVID-19 studies with constructs expressing the SARS-CoV-2 nucelocapsid protein (N protein) - based on SBI's robust lentivector
SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector
Streamline your COVID-19 studies with constructs expressing a humanized SARS-CoV-2 Spike Glycoprotein (S) - based on SBI's robust lentivector
SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector
Frontiers SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Two sides of the same evil. SARS-CoV-2 binds via its spike protein to
Vaccine-induced COVID-19 mimicry syndrome
S SARS-CoV-2 Spike Omicron mRNA (20 µg, Transfection-ready) - System Biosciences
RBD targeted COVID vaccine and full length spike-protein vaccine (mutation and glycosylation role) relationship with procoagulant effect
